Home LiteratureArticle Details
PMID: 7880386 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Is atherosclerosis an immunologically mediated disease?

Immunology today ·Vol. 16 ·No. 1 ·1995-01-00 ·Pages 27-33

Wick G, Schett G, Amberger A, Kleindienst R, Xu Q

Abstract

In contrast to general beliefs, recent data from different laboratories have provided evidence that the first stages of atherosclerosis are of an inflammatory nature. Here, Georg Wick and colleagues suggest that an autoimmune reaction against heat shock protein 60 (Hsp60), expressed by endothelial cells in areas that are subject to increased haemodynamic stress, is the initiating event in atherogenesis. Humoral and T-cell-mediated immune responses against Hsp60 have both been demonstrated early in disease. This inflammatory stage, which is reversible and has even been found in children, may progress into fully developed atherosclerotic lesions, displaying all the classical pathohistological and functional consequences, if additional risk factors such as high blood cholesterol levels, smoking and obesity, are present.

MeSH Terms
Animals Arteriosclerosis/immunology Autoantibodies/immunology Autoimmune Diseases/immunology Chaperonin 60/immunology Endothelium, Vascular/immunology Humans T-Lymphocytes/immunology
Chemicals
Autoantibodies Chaperonin 60
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Wick G
Institute for Biomedical Aging Research, Austrian Academy of Sciences, Innsbruck.
Schett G
Amberger A
Kleindienst R
Xu Q
Article Info
Journal
Immunology today
Abbr.
Immunol Today
ISSN
0167-5699
Published
1995-01-00
Pages
27-33
Language
English
Region
England
NLM ID
8008346
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com